Kenvue Inc. closed 4.37% below its 52-week high of $24.46, which the company achieved on November 26th.

Those who own JNJ stock may stay invested for some time to see how the company achieves growth in 2025 amid the various ...

That payout boost pushes the company's forward dividend yield up to 3.4%, more than double the S&P 500 's dividend yield of 1.4%. Johnson & Johnson's high-yielding payout is as healthy as they come, ...

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on ...

Kenvue (KVUE) entered a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital operations through advanced Artificial Intelligence ...

Kenvue (KVUE) announced a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital ...

Kenvue announced a five-year collaboration with Microsoft to transform digital operations through Artificial Intelligence (AI ...

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with ...

Edgewell's revenue and profit figures have seen declines, but shares are cheap, both absolutely and relative to peers. Click ...

Here are four US growth stocks that can recession-proof your investment portfolio. The post 4 Recession-Proof US Growth ...

J&J beats first-quarter earnings and sales estimates. It raises sales guidance for 2025 to reflect the addition of Caplyta ...

Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.